6-99439801-C-T
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001346022.3(USP45):c.2128G>A(p.Asp710Asn) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000547 in 1,607,218 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.00070 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00053 ( 1 hom. )
Consequence
USP45
NM_001346022.3 missense
NM_001346022.3 missense
Scores
6
6
7
Clinical Significance
Conservation
PhyloP100: 7.29
Genes affected
USP45 (HGNC:20080): (ubiquitin specific peptidase 45) The protein encoded by this gene is a deubiquitylase that binds ERCC1, the catalytic subunit of the XPF-ERCC1 DNA repair endonuclease. This endonuclease is a critical regulator of DNA repair processes, and the deubiquitylase activity of the encoded protein is important for maintaining the DNA repair ability of XPF-ERCC1. [provided by RefSeq, Sep 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 0 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.083295226).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
USP45 | NM_001346022.3 | c.2128G>A | p.Asp710Asn | missense_variant | 16/18 | ENST00000500704.7 | NP_001332951.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
USP45 | ENST00000500704.7 | c.2128G>A | p.Asp710Asn | missense_variant | 16/18 | 5 | NM_001346022.3 | ENSP00000424372 | P1 | |
USP45 | ENST00000327681.10 | c.2128G>A | p.Asp710Asn | missense_variant | 16/18 | 1 | ENSP00000333376 | P1 | ||
USP45 | ENST00000496518.6 | c.*1094G>A | 3_prime_UTR_variant, NMD_transcript_variant | 11/13 | 1 | ENSP00000421248 | ||||
USP45 | ENST00000369233.6 | c.1984G>A | p.Asp662Asn | missense_variant | 15/17 | 5 | ENSP00000358236 |
Frequencies
GnomAD3 genomes AF: 0.000697 AC: 106AN: 152092Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
106
AN:
152092
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000724 AC: 180AN: 248506Hom.: 0 AF XY: 0.000722 AC XY: 97AN XY: 134434
GnomAD3 exomes
AF:
AC:
180
AN:
248506
Hom.:
AF XY:
AC XY:
97
AN XY:
134434
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000531 AC: 773AN: 1455008Hom.: 1 Cov.: 30 AF XY: 0.000564 AC XY: 408AN XY: 723800
GnomAD4 exome
AF:
AC:
773
AN:
1455008
Hom.:
Cov.:
30
AF XY:
AC XY:
408
AN XY:
723800
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000696 AC: 106AN: 152210Hom.: 0 Cov.: 33 AF XY: 0.000699 AC XY: 52AN XY: 74418
GnomAD4 genome
AF:
AC:
106
AN:
152210
Hom.:
Cov.:
33
AF XY:
AC XY:
52
AN XY:
74418
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
0
ESP6500EA
AF:
AC:
11
ExAC
AF:
AC:
92
Asia WGS
AF:
AC:
2
AN:
3470
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 21, 2021 | The c.2128G>A (p.D710N) alteration is located in exon 16 (coding exon 15) of the USP45 gene. This alteration results from a G to A substitution at nucleotide position 2128, causing the aspartic acid (D) at amino acid position 710 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Pathogenic
DANN
Pathogenic
DEOGEN2
Benign
T;T;.
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Pathogenic
D
LIST_S2
Pathogenic
.;D;D
M_CAP
Benign
D
MetaRNN
Benign
T;T;T
MetaSVM
Benign
T
MutationAssessor
Uncertain
M;M;.
MutationTaster
Benign
D;D;D;D;D
PrimateAI
Uncertain
T
PROVEAN
Pathogenic
D;D;D
REVEL
Uncertain
Sift
Pathogenic
D;D;D
Sift4G
Pathogenic
D;D;D
Polyphen
D;D;.
Vest4
MVP
MPC
0.47
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at